KBC Group
INSM icon

KBC Group’s Insmed INSM Stock Holding History

KBC Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.11M Buy
37,347
+3,334
+10% +$513K 0.02% 435
2025
Q4 		$5.92M Buy
34,013
+24,396
+254% +$4.45M 0.01% 437
2025
Q3 		$1.39M Buy
9,617
+4,641
+93% +$569K ﹤0.01% 647
2025
Q2 		$501K Sell
4,976
-2,575
-34% -$197K ﹤0.01% 708
2025
Q1 		$576K Buy
7,551
+678
+10% +$51.9K ﹤0.01% 706
2024
Q4 		$475K Buy
6,873
+2,563
+59% +$185K ﹤0.01% 819
2024
Q3 		$315K Buy
4,310
+730
+20% +$53.9K ﹤0.01% 783
2024
Q2 		$240K Buy
3,580
+405
+13% +$15.7K ﹤0.01% 813
2024
Q1 		$86K Hold
3,175
– – ﹤0.01% 1210
2023
Q4 		$98K Hold
3,175
– – ﹤0.01% 1074
2023
Q3 		$80K Buy
+3,175
New +$72.6K ﹤0.01% 1104

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KBC Group's INSM Position: Q1 2026 in Review

KBC Group increased its Insmed (INSM) stake by 9.8% in Q1 2026, buying an estimated $513K and bringing the position to 37,347 shares worth $6.11M. The position accounts for 0.02% of the portfolio, ranked #435.

KBC Group first reported a position in INSM in Q3 2023 and has held it in 11 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • KBC Group held 37,347 shares of Insmed worth $6.11M as of Q1 2026.
  • KBC Group bought 3,334 Insmed shares in Q1 2026, an estimated $513K.
  • Insmed made up 0.02% of KBC Group's portfolio in Q1 2026, its #435 holding.
  • KBC Group first reported a position in Insmed in Q3 2023 and has held it in 11 quarters since.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.